ANI PHARMACEUTICALS, INC (ANIP) Net margin 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) net profit margin by fiscal year — reported net income divided by reported revenue.
8.9%FY2025 · since FY2016: 3.1% → 8.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.9% | +11.9 pp |
| FY2024 | -3.0% | -6.9 pp |
| FY2023 | 3.9% | +19.0 pp |
| FY2022 | -15.1% | +4.6 pp |
| FY2021 | -19.7% | -8.9 pp |
| FY2020 | -10.8% | -13.8 pp |
| FY2019 | 3.0% | -4.7 pp |
| FY2018 | 7.7% | +8.3 pp |
| FY2017 | -0.6% | -3.7 pp |
| FY2016 | 3.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Gross profitANIP Gross marginANIP Operating incomeANIP Operating marginANIP Operating cash flowANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →